VDR Gene Polymorphisms and Risk of Hepatocellular Carcinoma

Promoter methylation of certain tumor regulatory genes and hepatocellular carcinoma

Assessing TGF β1 Gene Expression as a Prognostic Marker for Hepatocellular Carcinoma Development in HCV patients receiving Direct-Acting Antiviral (DAAs) Therapy

The association between the survivin gene -31G/C polymorphism and risk of hepatocellular carcinoma in Egyptian population.

Pseurotin A Halts Hepatocellular Carcinoma Oncogenic Potential Through Tuning miR-30a and let-7i Tumor Suppressor miRNAs

Micro RNA 155 and Its Target Gene CTLA4 As a New Biomarker for Lymphocyte ‎Activation in HCV-Induced Liver Fibrosis and Hepatocellular Carcinoma

The role of Her 2 neu and N-cadherin expression in hepatocellular carcinoma

GFBR3 Promoter Methylation Is A Prognostic Indicator And Not Responding To Decitabine Treatment In Hepatocellular Carcinoma

T1107 polymer expressed potential anti-tumor effects against HepG2 cell line

P53 and endoglin, two biomarkers for predicting HBV and hepatocellular carcinoma in Egyptian patients